These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 27125241)

  • 21. Acceptability of oral versus rectal HIV preexposure prophylaxis among men who have sex with men and transgender women in Peru.
    Peinado J; Lama JR; Galea JT; Segura P; Casapia M; Ortiz A; Montano SM; Kochel T; Sánchez J
    J Int Assoc Provid AIDS Care; 2013; 12(4):278-83. PubMed ID: 23422742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV Prevention Method Preferences Within Sexual Partnerships Reported by HIV-Negative MSM and TW in Tijuana, Mexico.
    Pines HA; Patrick R; Smith DM; Harvey-Vera A; Blumenthal JS; Rangel G; Semple SJ; Patterson TL
    AIDS Behav; 2020 Mar; 24(3):839-846. PubMed ID: 30945030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Facilitators and barriers to medication adherence in an HIV prevention study among men who have sex with men in the iPrEx study in Chiang Mai, Thailand.
    Tangmunkongvorakul A; Chariyalertsak S; Amico KR; Saokhieo P; Wannalak V; Sangangamsakun T; Goicochea P; Grant R
    AIDS Care; 2013 Aug; 25(8):961-7. PubMed ID: 23252473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adherence to Pre-exposure Prophylaxis in Black Men Who Have Sex with Men and Transgender Women in a Community Setting in Harlem, NY.
    Colson PW; Franks J; Wu Y; Winterhalter FS; Knox J; Ortega H; El-Sadr WM; Hirsch-Moverman Y
    AIDS Behav; 2020 Dec; 24(12):3436-3455. PubMed ID: 32385678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors associated with self-reported adherence to daily oral pre-exposure prophylaxis among men who have sex with man and transgender women: PrEP Brasil study.
    Monteiro Spindola Marins L; Silva Torres T; Luz PM; Moreira RI; Leite IC; Hoagland B; Kallas EG; Madruga JV; Grinsztejn B; Veloso VG;
    Int J STD AIDS; 2021 Nov; 32(13):1231-1241. PubMed ID: 34311605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors Associated with PrEP Support and Disclosure Among YMSM and Transgender Individuals Assigned Male at Birth in Chicago.
    Phillips G; Raman A; Felt D; Han Y; Mustanski B
    AIDS Behav; 2019 Oct; 23(10):2749-2760. PubMed ID: 31228025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Qualitative Assessment of Alcohol Consumption and Sexual Risk Behaviors Among Men Who Have Sex With Men and Transgender Women in Peru.
    Vagenas P; Brown SE; Clark JL; Konda KA; Lama JR; Sánchez J; Duerr AC; Altice FL
    Subst Use Misuse; 2017 Jun; 52(7):831-839. PubMed ID: 28426357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Pre-Exposure Prophylaxis Cascade in At-Risk Transgender Men Who Have Sex with Men in the United States.
    Reisner SL; Moore CS; Asquith A; Pardee DJ; Mayer KH
    LGBT Health; 2021; 8(2):116-124. PubMed ID: 33567245
    [No Abstract]   [Full Text] [Related]  

  • 29. Impact of Estimated Pre-Exposure Prophylaxis (PrEP) Adherence Patterns on Bone Mineral Density in a Large PrEP Demonstration Project.
    Spinelli MA; Glidden DV; Anderson PL; Gandhi M; McMahan VM; Defechereux P; Schechter M; Veloso VG; Chariyalertsak S; Guanira JV; Bekker LG; Buchbinder SP; Grant RM
    AIDS Res Hum Retroviruses; 2019 Sep; 35(9):788-793. PubMed ID: 31119944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Considerations regarding antiretroviral chemoprophylaxis in MSM.
    Poynten IM; Zablotska I; Grulich AE
    Curr Opin HIV AIDS; 2012 Nov; 7(6):549-56. PubMed ID: 22918448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study.
    Molina JM; Charreau I; Spire B; Cotte L; Chas J; Capitant C; Tremblay C; Rojas-Castro D; Cua E; Pasquet A; Bernaud C; Pintado C; Delaugerre C; Sagaon-Teyssier L; Mestre SL; Chidiac C; Pialoux G; Ponscarme D; Fonsart J; Thompson D; Wainberg MA; Doré V; Meyer L;
    Lancet HIV; 2017 Sep; 4(9):e402-e410. PubMed ID: 28747274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY trial.
    Sagaon-Teyssier L; Suzan-Monti M; Demoulin B; Capitant C; Lorente N; Préau M; Mora M; Rojas Castro D; Chidiac C; Chas J; Meyer L; Molina JM; Spire B;
    AIDS Care; 2016; 28 Suppl 1(sup1):48-55. PubMed ID: 26883400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adherence to pre-exposure prophylaxis among men who have sex with men: A prospective cohort study.
    Qu D; Zhong X; Xiao G; Dai J; Liang H; Huang A
    Int J Infect Dis; 2018 Oct; 75():52-59. PubMed ID: 30125688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Effect of Depression on Adherence to HIV Pre-exposure Prophylaxis Among High-Risk South African Women in HPTN 067/ADAPT.
    Velloza J; Heffron R; Amico KR; Rowhani-Rahbar A; Hughes JP; Li M; Dye BJ; Celum C; Bekker LG; Grant RM;
    AIDS Behav; 2020 Jul; 24(7):2178-2187. PubMed ID: 31955360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre-exposure Prophylaxis Use and Medication Adherence Among Men Who Have Sex With Men: A Systematic Review of the Literature.
    Maxwell S; Gafos M; Shahmanesh M
    J Assoc Nurses AIDS Care; 2019; 30(4):e38-e61. PubMed ID: 31241514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing the Information-Motivation-Behavioral Skills Model to Predict Pre-exposure Prophylaxis Adherence Among Black Men Who have Sex with Men and Transgender Women in a Community Setting in New York City.
    Knox J; Kutner BA; Shiau S; Winterhalter FS; Wu Y; Hirsch-Moverman Y; El-Sadr W; Colson PW; Franks J
    AIDS Behav; 2022 Jul; 26(7):2494-2502. PubMed ID: 35098392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV sero disclosure among men who have sex with men and transgender women on HIV pre-exposure prophylaxis.
    Hojilla JC; Mehrotra M; Truong HM; Glidden DV; Amico KR; McMahan V; Vlahov D; Chariyalertsak S; Guanira JV; Grant RM; For The iPrEx Study Team
    AIDS Care; 2018 Apr; 30(4):466-472. PubMed ID: 29082776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Baseline Characteristics Explain Differences in Effectiveness of Randomization to Daily Oral TDF/FTC PrEP Between Transgender Women and Cisgender Men Who Have Sex With Men in the iPrEx Trial.
    Mehrotra ML; Westreich D; McMahan VM; Glymour MM; Geng E; Grant RM; Glidden DV
    J Acquir Immune Defic Syndr; 2019 Jul; 81(3):e94-e98. PubMed ID: 31192894
    [No Abstract]   [Full Text] [Related]  

  • 39. Individual-level characteristics associated with oral HIV test acceptability among Peruvian men who have sex with men and transgender women: a cross-sectional study.
    Flores JA; Brown B; León SR; Sánchez H; Galea JT
    Sex Transm Infect; 2018 Nov; 94(7):528-533. PubMed ID: 29574465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associations between perceived barriers and benefits of using HIV pre-exposure prophylaxis and medication adherence among men who have sex with men in Western China.
    Hu Y; Zhong XN; Peng B; Zhang Y; Liang H; Dai JH; Zhang JY; Huang AL
    BMC Infect Dis; 2018 Nov; 18(1):575. PubMed ID: 30442106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.